Please assess the completion status of the following clinical trial:

Trial Title: Visual Outcomes After Vivity Toric IOL Implantation

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Calculated lens power within study IOL range of 15.0 diopters to 25.0 diopters and toric range of T3 to T6~* Willing and able to comprehend informed consent form and to complete 1 day and 3-4 month postoperative visit~* Potential postoperative best corrected distance visual acuity of 20/20 or better in each eye based on medical opinion of investigator~Exclusion Criteria:~* Ocular pathology or comorbidity that could reduce potential postoperative best corrected distance visual acuity~* Ocular trauma or zonular weakness/instability~* Diagnosis of glaucoma or high-risk glaucoma suspect~* Previous refractive surgery~* Unreliable preoperative biometry measurements~* Severe dry eye or ocular surface disease

- Gender: ALL
- Minimum Age: 45 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Vivity Toric IOL (Type: OTHER): Patients with cataract that had phacoemulsification and Vivity Toric IOL implantation.

Based on this trial design, predict the completion outcome and termination type (if applicable).